Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q7MQ
|
||||
Former ID |
DNC000468
|
||||
Drug Name |
CP-100263
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Emesis [ICD9: 787; ICD10:R11] | Investigative | [1] | ||
Company |
Pfizer
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C19H24N2O
|
||||
Canonical SMILES |
COC1=CC=CC=C1CNC2CCCNC2C3=CC=CC=C3
|
||||
InChI |
1S/C19H24N2O/c1-22-18-12-6-5-10-16(18)14-21-17-11-7-13-20-19(17)15-8-3-2-4-9-15/h2-6,8-10,12,17,19-21H,7,11,13-14H2,1H3
|
||||
InChIKey |
DTQNEFOKTXXQKV-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 136982-37-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Substance-P receptor | Target Info | Antagonist | [1] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Measles | |||||
PANTHER Pathway | CCKR signaling map ST | ||||
Reactome | G alpha (q) signalling events | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Spinal Cord Injury | |||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Emerging drugs for chemotherapy-induced emesis. Expert Opin Emerg Drugs. 2006 Mar;11(1):137-51. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.